<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Ackermans &amp; Van Haaren Nv — News on 6ix</title>
    <link>https://6ix.com/company/ackermans-and-van-haaren-nv-1</link>
    <description>Latest news and press releases for Ackermans &amp; Van Haaren Nv on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 06 May 2026 05:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/ackermans-and-van-haaren-nv-1" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo69d68c97beedb30cb6feeee5.webp</url>
      <title>Ackermans &amp; Van Haaren Nv</title>
      <link>https://6ix.com/company/ackermans-and-van-haaren-nv-1</link>
    </image>
    <item>
      <title>Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors</title>
      <link>https://6ix.com/company/ackermans-and-van-haaren-nv-1/news/biotalys-obtains-subscription-commitments-for-eur-1205-million-through-a-private-placement-of-new-shares-with-current-investors-1</link>
      <guid isPermaLink="true">https://6ix.com/company/ackermans-and-van-haaren-nv-1/news/biotalys-obtains-subscription-commitments-for-eur-1205-million-through-a-private-placement-of-new-shares-with-current-investors-1</guid>
      <pubDate>Wed, 06 May 2026 05:00:00 GMT</pubDate>
      <description>Press release – regulated information – inside informationGhent, BELGIUM, May 06, 2026 (GLOBE NEWSWIRE) -- Public announcement in accordance with article 7:97,§4/1 of the Belgian Companies and Associations Code Biotalys (Euronext: BTLS) (the “Company” or “Biotalys”), today announced it has successfully obtained subscription commitments for new shares for an amount of EUR 12,050,000 through a private placement (“Private Placement”). The Private Placement involves the issue of 7,875,811 new shares</description>
    </item>
    <item>
      <title>DISCO Pharmaceuticals Appoints Mark Manfredi as CEO and Announces Final Close of €36 Million Seed Financing</title>
      <link>https://6ix.com/company/ackermans-and-van-haaren-nv-1/news/disco-pharmaceuticals-appoints-mark-manfredi-as-ceo-and-announces-final-close-of-euro36-million-seed-financing-1</link>
      <guid isPermaLink="true">https://6ix.com/company/ackermans-and-van-haaren-nv-1/news/disco-pharmaceuticals-appoints-mark-manfredi-as-ceo-and-announces-final-close-of-euro36-million-seed-financing-1</guid>
      <pubDate>Thu, 11 Dec 2025 10:00:00 GMT</pubDate>
      <description>Mark Manfredi brings over two decades of international biopharmaceutical industry leadership and cancer drug discovery success to DISCO Financing will support the development of novel surfaceome-targeted therapies for hard-to-treat tumors Cologne, Germany, December 11, 2025 – DISCO Pharmaceuticals (“DISCO”) today announced the appointment of seasoned biotech leader Mark Manfredi, Ph.D., as Chief Executive Officer (CEO), as well as the final close of a €36 million seed financing round to advance</description>
    </item>
    <item>
      <title>PUBLICATION OF ATRANSPARENCY NOTIFICATION - ACKERMANS &amp; VAN HAAREN</title>
      <link>https://6ix.com/company/ackermans-and-van-haaren-nv-1/news/publication-of-atransparency-notification-ackermans-and-van-haaren-1</link>
      <guid isPermaLink="true">https://6ix.com/company/ackermans-and-van-haaren-nv-1/news/publication-of-atransparency-notification-ackermans-and-van-haaren-1</guid>
      <pubDate>Mon, 03 Nov 2025 16:40:00 GMT</pubDate>
      <description>PUBLICATION OF ATRANSPARENCY NOTIFICATION - ACKERMANS &amp; VAN HAAREN Pursuant to article 14 of the law of 2 May 2007, Nextensa NV/SA announces that it has received a transparency notification dated 30 October 2025 from Ackermans &amp; van Haaren NV/SA (having its registered offices at Begijnenvest 113, 2000 Antwerp, Belgium). Ackermans &amp; van Haaren has notified that, following an acquisition of additional shares on 28 October 2025, its total number of voting rights in Nextensa increased to 80.31% of t</description>
    </item>
    <item>
      <title>Nokia expands defense portfolio with two advanced tactical communication solutions</title>
      <link>https://6ix.com/company/ackermans-and-van-haaren-nv-1/news/nokia-expands-defense-portfolio-with-two-advanced-tactical-communication-solutions-96</link>
      <guid isPermaLink="true">https://6ix.com/company/ackermans-and-van-haaren-nv-1/news/nokia-expands-defense-portfolio-with-two-advanced-tactical-communication-solutions-96</guid>
      <pubDate>Tue, 09 Sep 2025 07:00:00 GMT</pubDate>
      <description>Nokia Mission-Safe Phone Nokia Mission-Safe Phone Nokia Banshee 5G Tactical Radio Nokia Banshee 5G Tactical Radio Press Release Nokia expands defense portfolio with two advanced tactical communication solutions Introduces Nokia Mission-Safe Phone, a purpose-built defense smartphone for reliable mission-critical communications in the harshest operational environmentsNokia also launches the upgraded Banshee 5G Tactical Radio, a rugged, portable, easy-to-deploy network hub, now with integrated 5G c</description>
    </item>
  </channel>
</rss>